Related Experiment Video
Updated: Sep 1, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Implementing Collaborative Care Management of Behavioral Health for Patients with Inflammatory Bowel Disease
Christine B Flicek1, Nathaniel A Sowa1, Millie D Long2
1Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina, USA.
Collaborative care management (CoCM) shows promise for treating anxiety and depression in inflammatory bowel disease (IBD) patients. This team-based approach was feasible and well-accepted in a specialty clinic setting.
Area of Science:
- Gastroenterology
- Behavioral Health
- Healthcare Management
Background:
- Individuals with inflammatory bowel disease (IBD) experience higher rates of anxiety and depression.
- Collaborative care management (CoCM) is an evidence-based, team-based model for behavioral health disorders.
Purpose of the Study:
- To assess the feasibility and effectiveness of CoCM in reducing anxiety and depressive symptoms in IBD patients.
- To evaluate provider acceptance of the CoCM model in a specialty gastroenterology setting.
Main Methods:
- Patients with psychological distress were referred to the CoCM program.
- Data collected over 9 months assessed depression and anxiety response and remission rates.
- Provider surveys evaluated acceptability of the CoCM model.
Main Results:
- Despite pandemic interruptions, 47.4% of participants showed response or remission in depression, and 36.8% in anxiety.
- Gastroenterologists found the CoCM program beneficial and felt comfortable implementing recommendations.
Conclusions:
- CoCM is a potentially feasible and well-accepted care delivery model for managing depression and anxiety in IBD patients.
- The CoCM model can be effectively implemented in specialty gastroenterology clinics.
More Related Videos
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...